Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary
NCT ID: NCT04669756
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
409 participants
INTERVENTIONAL
2018-04-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Endometriosis on Pregnancy and Delivery - a Retrospective Cohort Study
NCT04664335
Post-operative Ovarian Adhesion Study in Women With Endometriosis
NCT01989260
Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier
NCT02165917
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence
NCT01092494
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma
NCT03430609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
ovariopexy for 2 days
ovariopexy
if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall
B
ovariopexy for 4 days
ovariopexy
if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall
C
ovariopexy for 6 days
ovariopexy
if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall
D
Placebo Operation for 2 days
placebo operation
in arm D sutures are transabdominal only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ovariopexy
if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall
placebo operation
in arm D sutures are transabdominal only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* wants to participate
* removal of endometriosis of the pelvic side wall or ovary
Exclusion Criteria
* cannot give informed consent
* no endometriosis during Operation
* no Opening of pelvic side wall or ovary during the Operation
* pregnant
* breast feeding
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. Sebastian Daniel Schäfer
Head of Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebastian D Schaefer, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Muenster, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Muenster
Münster, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Schäfer_Endo_Ovariopexie
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.